Use of intravenous vernakalant for atrial fibrillation conversion in the regular ward under only bedside monitoring

MLA

Sofia Metaxa, et al. “Use of Intravenous Vernakalant for Atrial Fibrillation Conversion in the Regular Ward under Only Bedside Monitoring.” Hellenic Journal of Cardiology, vol. 60, Jan. 2019, pp. 54–56. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4f282c4643bb18bf94861d8aa3e250ce&authtype=sso&custid=ns315887.

APA

Sofia Metaxa, Nikolaos Sakellaris, Antonis S. Manolis, Ioannis Pyrros, Kali Polytarchou, & Spyridon Bethanis. (2019). Use of intravenous vernakalant for atrial fibrillation conversion in the regular ward under only bedside monitoring. Hellenic Journal of Cardiology, 60, 54–56.

Chicago

Sofia Metaxa, Nikolaos Sakellaris, Antonis S. Manolis, Ioannis Pyrros, Kali Polytarchou, and Spyridon Bethanis. 2019. “Use of Intravenous Vernakalant for Atrial Fibrillation Conversion in the Regular Ward under Only Bedside Monitoring.” Hellenic Journal of Cardiology 60 (January): 54–56. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4f282c4643bb18bf94861d8aa3e250ce&authtype=sso&custid=ns315887.